Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

760.00 -11.55 (-1.50%)
Official Closing Price Updated: 4:10 PM EDT, May 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,081,724
Open 774.02
Bid (Size) 760.00 (2)
Ask (Size) 761.00 (10)
Prev. Close 771.55
Today's Range 760.00 - 777.42
52wk Range 419.80 - 800.78
Shares Outstanding N/A
Dividend Yield 0.59%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Highest And Lowest Price To Sales (P/S) Ratios
In the S&P 1500 there are just under 1,175 stocks that have positive next-year EPS estimates and trailing 12-month revenues of more than $1 billion. 
Via Talk Markets
Topics Stocks
Exposures US Equities
3 Biotech Stocks to Sell in May Before They Crash & Burn
Discover essential insights on biotech stocks to sell in May to navigate market volatility and safeguard your investment portfolio. 
Via InvestorPlace

Performance

YTD
+28.34%
+28.34%
1 Month
+0.36%
+0.36%
3 Month
+3.31%
+3.31%
6 Month
+28.53%
+28.53%
1 Year
+74.34%
+74.34%

More News

Read More
Can Weight Loss Companies Fuel Gains In Your Stock Portfolio?
Via Talk Markets
7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025
Via InvestorPlace
This 1 Simple ETF Could Turn $100 a Month Into $93,200
Via The Motley Fool
Topics ETFs
This Is What Whales Are Betting On Eli Lilly and Co
Via Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $2,200 Today
Via Benzinga
This Is What Whales Are Betting On Eli Lilly and Co
Via Benzinga
Google DeepMind Develops Latest AI Model To Aid Scientists In Fighting Disease
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Actinium Pharmaceuticals (NYSE: ATNM): A Prime Target in a Wave of Radiopharmaceutical Mergers and Acquisitions
Via AB Newswire
Hedge Fund Legend Druckenmiller Shares His Top Secrets For 30% Returns
Via Benzinga
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
What About Eli Lilly's Drug For Early Alzheimer's? FDA Panel To Discuss Next Month
Via Benzinga
Exposures Product Safety
Sigyn Therapeutics Discloses Publication of "Sigyn Therapy, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections"
Via NewMediaWire
Exposures COVID-19
Sigyn Therapeutics Discloses Publication of "Sigyn Therapy, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections"
Via TheNewswire.com
Exposures COVID-19
Why Eli Lilly Stock Jumped by 4% Today
Via The Motley Fool
3 Biotech Stocks to Double Your Money in the Next 24 Months
Via InvestorPlace
Eli Lilly Gains on the GLP-1 Weight Loss Phenomenon
Via MarketBeat
2 Top Stocks That Could Make You Richer in 2024
Via The Motley Fool
3 Super-Safe Dividend Stocks That Have Been Making Recurring Payments for 130+ Years
Via The Motley Fool
3 No-Brainer Stocks to Buy in May
Via The Motley Fool
Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making
Via The Motley Fool
Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?
Via The Motley Fool
Why Amgen Stock Zoomed Nearly 12% Higher Today
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.